Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 1
1982 2
1983 6
1984 3
1985 6
1986 6
1987 3
1988 2
1989 6
1990 4
1991 3
1992 1
1993 5
1994 6
1995 11
1996 3
1997 9
1998 4
2000 4
2001 6
2002 3
2003 3
2004 7
2005 5
2006 6
2007 9
2008 6
2009 4
2010 8
2011 5
2012 4
2013 7
2014 2
2015 3
2016 5
2017 2
2018 2
2019 5
2020 4
2021 2
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere.
Woodward DF, Wang JW, Stamer WD, Lütjen-Drecoll E, Krauss AH, Toris CB. Woodward DF, et al. J Ocul Pharmacol Ther. 2019 Nov;35(9):469-474. doi: 10.1089/jop.2019.0041. Epub 2019 Jul 19. J Ocul Pharmacol Ther. 2019. PMID: 31329508 Review.
Prostanoid receptor assays.
Chen J, Woodward DF, Coleman RA, Jones RL, Lydford SJ. Chen J, et al. Among authors: woodward df. Curr Protoc Pharmacol. 2001 Nov;Chapter 4:Unit4.18. doi: 10.1002/0471141755.ph0418s14. Curr Protoc Pharmacol. 2001. PMID: 21959759
Fixed-combination and emerging glaucoma therapies.
Woodward DF, Chen J. Woodward DF, et al. Expert Opin Emerg Drugs. 2007 May;12(2):313-27. doi: 10.1517/14728214.12.2.313. Expert Opin Emerg Drugs. 2007. PMID: 17604504 Review.
Functional rewiring of G protein-coupled receptor signaling in human labor.
Walker AR, Larsen CB, Kundu S, Stavrinidis C, Kim SH, Inoue A, Woodward DF, Lee YS, Migale R, MacIntyre DA, Terzidou V, Fanelli F, Khanjani S, Bennett PR, Hanyaloglu AC. Walker AR, et al. Among authors: woodward df. Cell Rep. 2022 Sep 6;40(10):111318. doi: 10.1016/j.celrep.2022.111318. Cell Rep. 2022. PMID: 36070698 Free PMC article.
The pharmacology of bimatoprost (Lumigan).
Woodward DF, Krauss AH, Chen J, Lai RK, Spada CS, Burk RM, Andrews SW, Shi L, Liang Y, Kedzie KM, Chen R, Gil DW, Kharlamb A, Archeampong A, Ling J, Madhu C, Ni J, Rix P, Usansky J, Usansky H, Weber A, Welty D, Yang W, Tang-Liu DD, Garst ME, Brar B, Wheeler LA, Kaplan LJ. Woodward DF, et al. Surv Ophthalmol. 2001 May;45 Suppl 4:S337-45. doi: 10.1016/s0039-6257(01)00224-7. Surv Ophthalmol. 2001. PMID: 11434936 Review.
Bimatoprost: a novel antiglaucoma agent.
Woodward DF, Phelps RL, Krauss AH, Weber A, Short B, Chen J, Liang Y, Wheeler LA. Woodward DF, et al. Cardiovasc Drug Rev. 2004 Summer;22(2):103-20. doi: 10.1111/j.1527-3466.2004.tb00134.x. Cardiovasc Drug Rev. 2004. PMID: 15179448 Review.
The inflow and outflow of anti-glaucoma drugs.
Woodward DF, Gil DW. Woodward DF, et al. Trends Pharmacol Sci. 2004 May;25(5):238-41. doi: 10.1016/j.tips.2004.03.002. Trends Pharmacol Sci. 2004. PMID: 15120486 Review.
174 results